🔎 Trials Near Me

Dachaigh › Neuroblastoma

Sgrùdaidhean clionaigeach Neuroblastoma a’ fastadh anns na SA

Tha 47 sgrùdaidhean airson Neuroblastoma a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.

Bailtean leis na sgrùdaidhean as motha

Le stàit

Sgrùdaidhean air an ùrachadh o chionn ghoirid

Teacsa sgrùdaidh oifigeil (Beurla)

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
4 Weeks · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT01109394

MCT for the Harvard/UCSF ROBIN Center

A’ fastadh
Gach aois · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06000787

A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
Gach aois · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT04936529

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

A’ fastadhSgrùdadh amharc
Aoisean 4 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT01005654

Biomarkers of Resiliency In Childhood Cancer Surgery

A’ fastadhSgrùdadh amharc
Aoisean 3 gu 25 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT06674811

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

A’ fastadhÌre 2
Suas gu aois 22 · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT02559778

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

A’ fastadhÌre 1/2
Suas gu aois 26 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06465199

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

A’ fastadhÌre 1/2
Suas gu aois 30 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06541262

B7-H3.CD28Z.CART in Solid Tumors

A’ fastadhÌre 1
9 Months – 30 Years · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT07358260

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

A’ fastadhÌre 2
Aoisean 1 gu 21 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06540963

International Congenital Central Hypoventilation Syndrome (CCHS) Registry and CCHS SHARE

A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT03088020

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

A’ fastadhÌre 2
18 Months – 19 Years · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT06528496

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

A’ fastadhÌre 3
365 Days – 30 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

A’ fastadhÌre 1/2
12 Months – 30 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04851119

Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Neuroblastoma

A’ fastadhÌre 2
Aoisean 1 gu 39 · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT07635056

Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)

A’ fastadhÌre 1
Aoisean 1 gu 23 · Gach gnè · Air ùrachadh 13 Lùna 2026 · NCT07172958

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

A’ fastadhÌre 2
12 Months – 21 Years · Gach gnè · Air ùrachadh 12 Lùna 2026 · NCT05489887

SPEARHEAD-3 Pediatric Study

A’ fastadhÌre 1/2
Aoisean 2 gu 21 · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT05642455

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

A’ fastadhÌre 2
Gach aois · Gach gnè · Air ùrachadh 28 Iuch 2026 · NCT06057948

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

A’ fastadhÌre 1/2
Aoisean 1 gu 30 · Gach gnè · Air ùrachadh 22 Iuch 2026 · NCT06721689

NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma

A’ fastadhÌre 1
Aoisean 1 gu 24 · Gach gnè · Air ùrachadh 21 Iuch 2026 · NCT07211737

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

A’ fastadhÌre 2
Aoisean 1 gu 31 · Gach gnè · Air ùrachadh 20 Iuch 2026 · NCT06450041

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.